109 related articles for article (PubMed ID: 22290567)
1. Has the survival rate for surgically resected gastric gastrointestinal stromal tumors improved in the tyrosine kinase inhibitor era?
Pedroso FE; Raut CP; Xiao H; Yeo CJ; Koniaris LG
Ann Surg Oncol; 2012 Jun; 19(6):1748-58. PubMed ID: 22290567
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
3. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
Perez EA; Livingstone AS; Franceschi D; Rocha-Lima C; Lee DJ; Hodgson N; Jorda M; Koniaris LG
J Am Coll Surg; 2006 Apr; 202(4):623-9. PubMed ID: 16571433
[TBL] [Abstract][Full Text] [Related]
4. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
7. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
8. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.
Artinyan A; Kim J; Soriano P; Chow W; Bhatia S; Ellenhorn JD
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2194-201. PubMed ID: 18708414
[TBL] [Abstract][Full Text] [Related]
9. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
Hsu KH; Yang TM; Shan YS; Lin PW
Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
[TBL] [Abstract][Full Text] [Related]
10. A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era.
Reece-Smith AM; MacGoey P; Shah MA; Leeder P; Andrew DR; McCulloch T; Parsons SL
Eur J Surg Oncol; 2012 Jun; 38(6):484-9. PubMed ID: 22342866
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and outcome of resected patients for gastrointestinal stromal tumors.
Chiappa A; Zbar AP; Biffi R; Bertani E; Pace U; Pruneri G; Della Vigna P; Grassi C; Valerio M; Poldi D; Andreoni B
Hepatogastroenterology; 2007; 54(75):693-6. PubMed ID: 17591043
[TBL] [Abstract][Full Text] [Related]
12. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST).
Hohenberger P; Eisenberg B
Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930
[TBL] [Abstract][Full Text] [Related]
13. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era.
Iesalnieks I; Rümmele P; Dietmaier W; Jantsch T; Zülke C; Schlitt HJ; Hofstädter F; Anthuber M
Am J Clin Pathol; 2005 Nov; 124(5):740-8. PubMed ID: 16203282
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment for gastrointestinal stromal tumor].
Wan DS; Wu XJ; Ding PR; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Kong LH; Liang XM; Luo RZ
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(15):1037-40. PubMed ID: 18005584
[TBL] [Abstract][Full Text] [Related]
16. The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study.
Weksler B; Shende M; Nason KS; Gallagher A; Ferson PF; Pennathur A
Ann Thorac Surg; 2012 Jun; 93(6):1822-8; discussion 1828-9. PubMed ID: 22551847
[TBL] [Abstract][Full Text] [Related]
17. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
20. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
Heinrich MC; Corless CL
J Surg Oncol; 2005 Jun; 90(3):195-207; discussion 207. PubMed ID: 15895440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]